Arkema is engaged in the global chemical industry which is a processing industry based on the transformation in one or several stages of raw materials (oil derivatives, gas, minerals, natural products) into more or less complex chemical products, or into plastics obtained by polymerization. In addition, Co. manufactures a wide range of products for other major industries: construction, packaging, chemicals, automotive, electronics, food manufacturing, pharmaceuticals, etc. Co. operates in this industrial context with a business portfolio focused on three segments: High Performance Materials, Industrial Specialties, and Coating Solutions.
  • TickerAKE
  • ISINFR0010313833
  • ExchangeEuronext Paris
  • SectorChemicals
  • CountryFrance

Analysts

Baptiste Lebacq ...
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Geoffroy Michalet
  • Jean Sassus
  • Jean-François Granjon
  • Nicolas David

ODDO BHF Small & MIDCAP MORNING NEWS - 03/04/2019

...

Alfred Glaser ...
  • Antoine Boivin-Champeaux
  • Bruno Cavalier
  • Delphine Brault
  • Emira Sagaama
  • Emmanuel Matot
  • François Maury
  • Geoffroy Michalet
  • Georges Dieng
  • Jean Sassus
  • Jerôme Bodin
  • Martial Descoutures
  • Matthias Desmarais
  • Pierre Corby
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 03/04/2019

...

Emmanuel Matot

Arkema : Feedback from roadshow: specialities take over intermediates

>Management's main messages - Following the publication of full-year results last week, we organised a roadshow in Paris for management (CEO, CFO and IRs). We note the following points:2018 was an excellent year (EBITDA = +6% to € 1,474m vs guidance = +5%), especially since the base of comparison was high (note 2017 EBITDA = +17%). The specialties segment has been buoyant (especially advanced materials and thiochemistry), although its performance was somewhat mas...

Baptiste Lebacq ...
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Geoffroy Michalet
  • Jean Sassus
  • Jean-François Granjon
  • Nicolas David

ODDO BHF Small & MIDCAP MORNING NEWS - 04/03/2019

...

Arkema: Update to discussion of key credit factors following change of outlook to positive

Deleveraging and higher share of specialty chemicals make Arkema more resilient and support change of outlook to positive

Arkema - September 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's changes Arkema's outlook to positive; affirms Baa2 rating

Moody's Investors Service today changed Arkema's rating outlook to positive from stable and affirmed its Baa2 long-term issuer rating. A list of affected ratings can be found below. "By changing Arkema's outlook to positive we have taken into account the deleveraging track record fro...

Arkema - June 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Arkema - December 2017 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Alfred Glaser ...
  • Antoine Boivin-Champeaux
  • Bruno Cavalier
  • Delphine Brault
  • Emira Sagaama
  • Emmanuel Matot
  • François Maury
  • Geoffroy Michalet
  • Georges Dieng
  • Jean Sassus
  • Jerôme Bodin
  • Martial Descoutures
  • Matthias Desmarais
  • Pierre Corby
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 03/04/2019

...

Emmanuel Matot

Arkema : Feedback from roadshow: specialities take over intermediates

>Management's main messages - Following the publication of full-year results last week, we organised a roadshow in Paris for management (CEO, CFO and IRs). We note the following points:2018 was an excellent year (EBITDA = +6% to € 1,474m vs guidance = +5%), especially since the base of comparison was high (note 2017 EBITDA = +17%). The specialties segment has been buoyant (especially advanced materials and thiochemistry), although its performance was somewhat mas...

Alfred Glaser ...
  • Antoine Boivin-Champeaux
  • Bruno Cavalier
  • Delphine Brault
  • Emira Sagaama
  • Emmanuel Matot
  • François Maury
  • Geoffroy Michalet
  • Georges Dieng
  • Jean Sassus
  • Jerôme Bodin
  • Martial Descoutures
  • Matthias Desmarais
  • Pierre Corby
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 04/03/2019

...

Emmanuel Matot

Arkema : Feedback road-show : les spécialités en relais des intermédiaires

>Principaux messages des dirigeants - Suite à la publication des résultats annuels la semaine dernière, nous avons organisé un roadshow à Paris pour les dirigeants (CEO, CFO et IRs). Nous retiendrons :2018 a été une excellente année (EBITDA = +6% à 1 474 M€ vs guidance = +5%), d’autant que la base de comparaison était élevée (rappel EBITDA 2017 = +17%). Les spécialités se sont bien comportées (surtout les matériaux avancés et la thiochimie) même si leurs performa...

Rob Hales

Morningstar | Arkema's 4Q and Modest 2019 Guidance in Line With Our Expectations; Shares Fairly Valued

No-moat Arkema reported fourth-quarter results that were broadly in line with consensus and our expectations. Fourth-quarter EBITDA increased 1.4% over 2017 while full-year EBITDA was up 6%, in line with guidance for a mid-single-digit increase. Guidance for 2019 is modest. EBITDA growth is expected to be flat for the year (despite a 3% boost from accounting changes) with a slight decline in the first quarter, given a high comparable. Currently, our forecast calls for a 4% EBITDA decline, which is basically in line with guidance after incorporating the accounting changes. Consequently, we don’...

2 directors sold after exercising options/sold

Two Directors at Arkema sold after exercising options/sold 21,300 shares at between 107.950EUR and 109.450EUR. The significance rating of the trade was 94/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is re...

Baptiste Lebacq ...
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Geoffroy Michalet
  • Jean Sassus
  • Jean-François Granjon
  • Nicolas David

ODDO BHF Small & MIDCAP MORNING NEWS - 03/04/2019

...

Baptiste Lebacq ...
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Geoffroy Michalet
  • Jean Sassus
  • Jean-François Granjon
  • Nicolas David

ODDO BHF Small & MIDCAP MORNING NEWS - 04/03/2019

...

Alain William ...
  • Antoine Boivin-Champeaux
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Florent Laroche-Joubert
  • François Maury
  • Georges Dieng
  • Louis Boujard
  • Philippe Ourpatian
  • Pierre Tegner
  • Rémi Adam
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 02/27/2019

This is the thirteenth update of our report on Corporate Governance large caps Europe. We have analysed 125 of the European companies covered by ODDO BHF analysts. In the Strong opportunities (1), we favour five stocks: Unibail Rodamco (Buy, target price € 190.0), AXA (Buy, target price € 28.0), Veolia (Buy, target price € 30.0), Danone (Buy, target price € 81.0) and Michelin (Buy, target price € 130.0). - Cf. report published today. - ...

Alain William ...
  • Antoine Boivin-Champeaux
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Florent Laroche-Joubert
  • François Maury
  • Georges Dieng
  • Louis Boujard
  • Philippe Ourpatian
  • Pierre Tegner
  • Rémi Adam
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 27/02/2019

13ème mise à jour de notre étude Corporate Governance Large caps Europe. Nous avons étudié 125 valeurs, toutes suivies par les analystes d’Oddo BHF. Nous privilégions 5 valeurs dans les opportunités fortes : Unibail Rodamco (Achat, OC 190.0 €), AXA (Achat, OC 28.0 €), Veolia (Achat, 30.0 €), Danone (Achat, 81.0 €) et Michelin (Achat, 130.0 €). Cf. étude publiée ce matin. - ...

Emira Sagaama ...
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Matthias Desmarais
  • Nicolas Thorez
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 02/27/2019

...

ARKEMA sees an upgrade to Slightly Positive due to a better fundamental star rating

The general evaluation of ARKEMA (FR), a company active in the Commodity Chemicals industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date January 18, 2019, the closing price was EUR 84.00 and its potential was estimated at EUR 90.17.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Carole Braudeau

Accor : Credit Feedback – Oddo BHF Forum 10 and 11 January

Our annual Forum in Lyon brought together 263 companies, including 41% of foreign companies, nearly 545 investors (33% foreigners), almost 6,500 one-to-one meetings. - This document gathers a brief feedback from the bond issuers and CB underlying companies in attendance. - - - - >Investment Grade - Accorhotels, Aéroports de Paris, Arkema, Buzzi Unicem, Carmila, Coface, Easyjet, Edenred, Fresenius Medical Care, Grand City Properties, Icade, JCDecaux, Klépierre, Lanxess, MT...

Carole Braudeau

Accor : Feedback Crédit Forum des 10 et 11 janvier 2019

Notre Forum annuel Oddo BHF 2019 vient de se dérouler à Lyon : il a réuni 263 sociétés, dont 41% étrangères, près de 545 investisseurs (33% étrangers), soit près de 6 500 one-to-one. - Ce document synthétise nos feed-back concernant les émetteurs obligataires présents et sous-jacents d’obligations convertibles. - - - >Investment Grade - Accorhotels, Aéroports de Paris, Arkema, Buzzi Unicem, Carmila, Coface, Easyjet, Edenred, Fresenius Medical Care, Grand City Properties,...

Arkema - Assemblée générale des actionnaires du 21 mai 2019

Proxinvest publiera une étude analysant les résolutions proposées lors de la tenue de l’assemblée générale des actionnaires. Vous pouvez l'acquérir dès à présent et elle vous sera adressée par ResearchPool une fois publiée.

Arkema – Proxinvest Corporate Governance Rating ® : D

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

Jehanne Leroy

Proxy Report - 18/05/2018

The remuneration awarded to Thierry Le Hénaff, Chairman & CEO, was excessive in 2017. He received € 4.5 M and may receive the same amount next year. Moreover the long term years of this directors, François Enaud and Thierry Morin, reduce the independent rate of the board of directors.

Jehanne Leroy

Proxy Report - 18/05/2018

Cette année, Proxinvest attire de nouveau l'attention des actionnaires sur la rémunération attribuée et la rémunération attribuable à M. Le Hénaff qui paraissent excessive. Ainsi en 2017, le Président Directeur Général a perçu un peu plus de 4,5 M d'euros; et pourrait se voir attribuer pas moins de la même somme en 2018. Ces rémunérations excessives sont étonnantes, surtout pour une entreprise étant membre du SBF 120. Le conseil comprendra avec un nouvel administrateur. Cependant deux administrateurs seront requalifiés à raison de leurs anciennetés dans la société. De ce fait, le taux d'indép...

Jérôme VINERIER

Short term view - ARKEMA : Falling prices.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at €87.81. The background trend would be questioned should prices rise above €99.54.

Jérôme VINERIER

Analyse court terme - ARKEMA : Les prix baissent.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 87,81 €. La tendance de fond serait remise en cause en cas de franchissement de 99,54 €.

Jérôme VINERIER

Short term view - ARKEMA : The background trend is clearly bearish.

The background trend is clearly bearish. The movement goes on. The next target is at €87.81, then €84.28. Passing €99.54 would question the continuation of the fall.

Jérôme VINERIER

Analyse court terme - ARKEMA : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Le mouvement se poursuit. Le prochain objectif est à 87,81 €, puis 84,28 €. Le franchissement de 99,54 € remettrait en cause la suite de la baisse.

Jérôme VINERIER

Medium term view - ARKEMA : The trend is uncertain.

The trend is uncertain. Prices are falling and they may accelerate to the downside. A new bearish trend is attempting to emerge.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch